Per Svensson - I Tech Sales Director

ITECH Stock

SEK 47.80 2.60 5.75%

Insider

Per Svensson is Sales Director of I Tech

Phone	46 10 30 33 999
Web	https://www.i-tech.se

I Tech Management Efficiency

The company has return on total asset (ROA) of 0.0201 % which means that it generated a profit of $0.0201 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0427 %, meaning that it generated $0.0427 on every $100 dollars invested by stockholders. I Tech's management efficiency ratios could be used to measure how well I Tech manages its routine affairs as well as how well it operates its assets and liabilities.

Compare I Tech to Peers

Predict price of I Tech

I Tech has accumulated 2.25 M in total debt with debt to equity ratio (D/E) of 11.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. I Tech has a current ratio of 8.41, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist I Tech until it has trouble settling it off, either with new capital or with free cash flow. So, I Tech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like I Tech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ITECH to invest in growth at high rates of return. When we think about I Tech's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives			INSIDER Age
	Jan Mattsson	BioArctic AB	63
	Sren MSc	Hansa Biopharma AB	58
	Emanuel Bjrne	Hansa Biopharma AB	50
	Harald Borgeke	BioArctic AB	N/A
	Johanna Flting	BioArctic AB	51
	Christer Mller	BioArctic AB	64
	Anette Lindqvist	Xbrane Biopharma AB	57
	Pr Lannfelt	BioArctic AB	74
	Nina Ivers	Xbrane Biopharma AB	53
	Erik Domines	Xbrane Biopharma AB	59
	Frida Lekander	BioArctic AB	N/A
	Oskar Bosson	BioArctic AB	47
	Martin mark	Xbrane Biopharma AB	43
	Gunilla Osswald	BioArctic AB	62
	Katja Margell	Hansa Biopharma AB	N/A
	Anne Lanner	Hansa Biopharma AB	54
	Pr Gellerfors	BioArctic AB	76
	David Vikstrm	Xbrane Biopharma AB	46
	Klaus Sindahl	Hansa Biopharma AB	N/A
	Samuel Wagner	Xbrane Biopharma AB	N/A
	Maria Edebrink	Xbrane Biopharma AB	54

I-Tech AB, a bio-technology company, develops and commercializes fouling prevention products in Sweden. The company was founded in 2000 and is based in Mlndal, Sweden. I Tech is traded on Stockholm Stock Exchange in Sweden. I Tech (ITECH) is traded on Stockholm Exchange in Sweden and employs 9 people.

Management Performance

	Return On Equity	0.0427
	Return On Asset	0.0201

I Tech Leadership Team

Elected by the shareholders, the I Tech's board of directors comprises two types of representatives: I Tech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ITECH. The board's role is to monitor I Tech's management team and ensure that shareholders' interests are well served. I Tech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, I Tech's outside directors are responsible for providing unbiased perspectives on the board's policies.

	Philip Chaabane, Chief Officer
	Cecilia Ohlauson, Head of Regulatory Affairs
	Per Svensson, Sales Director
	Markus Hoffmann, Technical Director
	Magnus Henell, CFO Operations

ITECH Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is I Tech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	0.0427
	Return On Asset	0.0201
	Profit Margin	0.07 %
	Operating Margin	0.06 %
	Current Valuation	662.35 M
	Shares Outstanding	11.91 M
	Shares Owned By Insiders	31.33 %
	Shares Owned By Institutions	37.93 %
	Price To Book	6.21 X
	Price To Sales	10.48 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for ITECH Stock Analysis

When running I Tech's price analysis, check to measure I Tech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy I Tech is operating at the current time. Most of I Tech's value examination focuses on studying past and present price action to predict the probability of I Tech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move I Tech's price. Additionally, you may evaluate how the addition of I Tech to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC